questionText: To ask the Secretary of State for Health and Social Care, who has responsibility for preventing the availability of products containing Melanotan II in England; and what steps he has taken to tackle the availability of these products.
answerText: The Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis taking into account the definition of a medicine in The Human Medicines Regulations 2012, relevant case law, and...
heading: Cosmetics: Afamelanotide